NDUFB8 and neoplasm: Additionally, knockout of nicotinamide adenine dinucleotide phosphate (NADH) dehydrogenase ubiquinone 1 β subcomplex (NDUFB)8 in combination with ICI led to slower tumor growth compared to WT NDUFB8 groups treated with anti-PD-L1.